Researchers at TRI are studying molecular mechanisms that contribute to metabolic and cardiovascular homeostasis in the body, to develop improved diagnosis and treatment options for conditions including diabetes and cardiovascular disease.

Metabolic and cardiovascular processes often become defective in obesity, resulting in the development of chronic diseases such as type 2 diabetes and cardiovascular disease. In vitro and in vivo systems are used together with a range of techniques involving molecular and cellular biology combined with biochemistry and ‘omics’ approaches to define molecular mechanisms that contribute to cardiometabolic health.

Key Researchers
Jon Whitehead
John Prins
Michael McGuckin
Emma Hamilton-Williams
Ranjeny Thomas
Show More ...
Key Aims
  • To identify novel strategies to reduce cardiometabolic disease.
William Tell and Obesity- first find the target Professor Clarke is Chairman of the Department of Physiology at Monash University. His expertise is in the field of neuroendocrinology and the central...Read more
participate, legislate or weight? The first of the Translational Research Institute (TRI) Research Committee’s breakfast symposiums explored the current prevention measures and treatments for...Read more
qld forum to look at nation's top killer Top minds in health and medical research are meeting in Brisbane today to discuss ways to beat chronic diseases, the nation’s leading cause of death...Read more